click below
click below
Normal Size Small Size show me how
CardiacDrugs
cardiac drugs
Question | Answer |
---|---|
Blood Pressure = | Cardiac Output x Systemic Vascular resistance |
Cardiac Output effects | Cardiac Factors:Heart Rate,ContractibilityCirculating Volume: Salt, Aldosterone |
Cardiac Factors: Heart Rate, Contractibility Drugs | Beta-blockers,Calcium Channel Blockers, Centrally Acting adrenergics. |
Circulating Volume: Salt, Aldosterone Drugs | ACE Inhibitors,Diuretics |
Systemic Vascular Resistance effects | Hormones:vasodilators,vasoconstrictors,Peripheral sympathetic receptors:Constrictors,Dilators,CNS,Local |
Hormones:Vasodilators,Vasoconstrictors effect and drugs | Vasodilators,Prostaglandins,ACE inhibitors,Calcium Channel blockers,Angiotensin II blockers |
Peripheral Sympathetic receptors: Constrictors,dilators effect Receptors | Alpha 1.alpha1-blockers, Beta 1. Beta-blockers |
CNS | Centrally acting adrenergics |
Local | Peripherally acting adrenergics |
Autonomic Nervous System | Parasympathetic nervous system: Stimulates smooth muscle,cardiac muscle,glands. Sympathetic nervous system: Stimulates the heart,blood vessels skeletal muscle. |
Andrenergic Drugs : 5 subcategories | Centrally and peripherally acting adrenergic neuron blockers. Centrally acting a2-receptor agonists. Peripherally acting a1-receptor blockers. Peripherally acting B-receptor blockers. -cardioselective(B1receptors) -nonselective(both B1&B2 receptors) |
Andrenergic Drugs : 5 subcategories cont'd. | Peripherally acting dual a1-and B-receptor blockers |
Adrenergic Drugs:MOA Centally acting a2-receptor agonists | Stimulate a2-receptors in the brain Sympathetic ouflow from the CNS is decreased Norepinephrine production is decreased Stimulation of the a2-adrenergic receptors reduces renin activity in the kidneys. RESULT:DECREASED BLOOD PRESSURE |
Adrenergic Drugs:MOA Centally acting a2-receptor agonists Prototype Drugs | clonidine(Catapres) guanfacine(Tenex) methyldopa(Aldomet) -Drug of choice fo hypertension in pregnancy |
Adrenergic Drugs:MOA Peripheral a1-blockers/antagonists | Block the a1-adrenergic receptors RESULT:DECREASED BLOOD PRESSURE |
Peripheral a1-blockers/antagonists Prototype Drugs (end in zosin) | doxazosin(Cardura) prazosin(Minipress) terazosin(Hytrin) |
Angiotensin Converting Enzyme Inhibitors ACE inhibitors MOA | DECREASE PERIPHERAL VASCULAR RESISTANCE w/o: Increasing Cardiac Output,w/o increasing cardiac rate and w/o increasing cardiac contractility |
Angiotensin Converting Enzyme Inhibitors ACE inhibitors Effects | Dizziness, Orthostatic hypotension,GI Distress, nonproductive cough,headache. |
Angiotensin Converting Enzyme Inhibitors ACE inhibitors Prototype drugs (end in pril) | Captopril(Capoten) Enalapril(Vasotec) Benzapril(Lotensin) Lisinopril(Zestril) Quinapril(Accupril) |
Angiotensin Converting Enzyme Inhibitors ACE inhibitors MOA on RAAS | Renin-Angiotensin-Aldosterone System Inhibit angiotensin-converting enzyme,which is responsible for converting angiontensin 1(through the action of renin)to angiontensinII |
Angiotensin Converting Enzyme Inhibitors ACE inhibitors MOA on RAAS cont'd. | AngiotensinII is apotent vasoconstrictor and causes aldosterone secretion from the adrenals Aldosterone stimualtes water and sodium resorption RESULT: INCREASED BLOOD VOLUME,INCREASED PRELOAD,AND INCREASED BP. |
Angiotensin Converting Enzyme Inhibitors ACE inhibitors MOA | Block the angiotensin converting enzyme,thus preventing the formation of angiotensinII Also prevent the breakdown of the vasodilating substance,bradykinin RESULT:DECREASE SYSTEMIC VASCULAR RESISTANCE(AFTERLOAD),VASODILATON,AND THEREFORE DECREASE BP |
ACE Inhibitors: Indications | HTN,HF(either alone or in combination w/diuretics or other drugs),To slow progression of left ventricular hypertrophy after MI(cardioprotective),Renal protective effects in patients w/diabetes.Drugs of choice in HTN pt's w/HF.Drug of choice for Dibetics. |
ACE Inhibitors Adverse Effects | Fatigue,HA,Impaired taste,Dizziness,Mood Changes,possible hyperkalemia,dry,nonproductive cough,which reversed after therapy is stopped.Angioedema:rare but potentially fatal.1st dose hypotension may occur! |
Angiotensin II Receptor Blocker (AII blockers or ARBs) | Newer class, well tolerated,do not cause a dry cough,allow angiotensin I to be converted to angiontensin II,but block the receptors that receive angiotensinII,Block vasoconstiction and release of aldosterone. |
Angiotensin II Receptor Blocker (AII blockers or ARBs) Indications | HTN,Adjunctive drugs for the tx of HF,May be used alone or w/other drugs such as diuretics,Used primarily in pt's who cannot tolerate ACE inhibitors |
Angiotensin II Receptor Blocker (AII blockers or ARBs) Prototype drugs (end in satran) | Iosartran(Coazar,Hyzaar) valsartan(Diovan) eprosartan irbesartan |
Angiotensin II Receptor Blocker (AII blockers or ARBs) Adverse Effects | Upper respiratory infections,HA,may cause occasional dizziness,inability to sleep,diarrhea,dyspnea,heartburn,nasal congestion,back pain,fatigue,hyperkalemia much less likel to occur. |
Calcium Channel Blockers MOA | Cause smooth muscle relaxation by blocking the binding of Ca to its receptors,preventing muscle contraction.This causes decreased peripheral smooth muscle tone and decreased systemic vascular resistance.RESULTS:DECREASED BLOOD PRESSURE |
Calcium Channel Blockers MOA | Blocks Ca access to cells causing decreased contractility & decreased conductivity of the heart=decreased demand for oxygen |
Calcium Channel Blockers Side effects | Decrease BP,bradycardia, may precipitate A-V Block,HA,abdominal discomfort(constipation,nausea)peripheral edema. |
Calcium Channel Blockers Prototype Drugs (Very Nice Drugs) | Verapamil Nifedipine Ditiazem |
B-blockers | Act in the periphery, reduce heart rate due to B1-blockade. |
B-blockers Prototype Drugs (end in olol) | Inderal(Propanolol) Tenormin(Atenolol) |